TLOG (TetraLogic Pharmaceuticals) Ending Cash Position: $5.89 Mil (As of Sep. 2016)


What is TetraLogic Pharmaceuticals Ending Cash Position?

TetraLogic Pharmaceuticals TLOG Ending Cash Position is $5.89 Mil as of Sep. 2016.

TetraLogic Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2016 was $5.89 Mil.

TetraLogic Pharmaceuticals's quarterly Ending Cash Position declined from Mar. 2016 ($14.54 Mil) to Jun. 2016 ($8.68 Mil) and declined from Jun. 2016 ($8.68 Mil) to Sep. 2016 ($5.89 Mil).

TetraLogic Pharmaceuticals's annual Ending Cash Position declined from Dec. 2013 ($55.14 Mil) to Dec. 2014 ($13.07 Mil) but then increased from Dec. 2014 ($13.07 Mil) to Dec. 2015 ($15.30 Mil).

TetraLogic Pharmaceuticals Ending Cash Position Related Terms

TetraLogic Pharmaceuticals Ending Cash Position Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Ending Cash Position Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Ending Cash Position
10.01 4.51 55.14 13.07 15.30

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.91 15.30 14.54 8.68 5.89

TetraLogic Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

TetraLogic Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2015 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=13.072+2.23
=15.30

TetraLogic Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2016 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=8.675+-2.79
=5.89

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $5.89 Mil mean?
TetraLogic Pharmaceuticals (TLOG) has a Ending Cash Position of $5.89 Mil as of Sep. 2016. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Ending Cash Position too high?
TetraLogic Pharmaceuticals' current Ending Cash Position is $5.89 Mil.
How does TetraLogic Pharmaceuticals' Ending Cash Position compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Ending Cash Position of $5.89 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current Ending Cash Position is $5.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Ending Cash Position of $5.89 Mil. The current Ending Cash Position is $5.89 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Ending Cash Position is $5.89 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.